Updated Genetic Testing of Primary Hyperoxaluria Type 1 in a Chinese Population: Results from a Single Center Study and a Systematic Review
- PMID: 30341509
- DOI: 10.1007/s11596-018-1941-y
Updated Genetic Testing of Primary Hyperoxaluria Type 1 in a Chinese Population: Results from a Single Center Study and a Systematic Review
Abstract
Primary hyperoxaluria type 1 (PH1) is a rare but devastating autosomal recessive inherited disease caused by mutations in gene AGXT. Pathogenic mutations of AGXT were mostly reported in Caucasian but infrequently in Asian, especially in Chinese. To update the genotypes of PH1 in the Chinese population, we collected and identified 7 Chinese probands with PH1 from 2013 to 2017 in our center, five of whom had delayed diagnosis and failed in kidney transplantation. Samples of peripheral blood DNA from the 7 patients and their family members were collected and sequencing analysis was performed to test the mutations of gene AGXT. Western blotting and enzyme activity analysis were conducted to evaluate the function of the mutations. Furthermore, a systematic review from 1998 to 2017 was performed to observe the genetic characteristics between Chinese and Caucasian. The results showed that a total of 12 mutations were identified in the 7 pedigrees. To the best of our knowledge, 2 novel variants of AGXT, p.Gly41Trp and p.Leu33Met, were first reported. Bioinformatics and functional analysis showed that only 7 mutations led to a reduced expression of alanine-glyoxylate amino transferase (AGT) at a protein level. The systematic review revealed significant population heterogeneity in PH1. In conclusion, new genetic subtypes and genetic characteristics of PH1 are updated in the Chinese population. Furthermore, a genotype-phenotype correlation is found in PH1.
Keywords: AGXT; Chinese population; gene sequencing; primary hyperoxaluria type 1.
Similar articles
-
A novel nonsense variant of the AGXT identified in a Chinese family: special variant research in the Chinese reference genome.BMC Nephrol. 2021 Mar 10;22(1):83. doi: 10.1186/s12882-021-02276-3. BMC Nephrol. 2021. PMID: 33691640 Free PMC article.
-
A Putative Mutation Hotspot of the AGXT Gene Associated with Primary Hyperoxaluria Type 1 in the Chinese Population.Tohoku J Exp Med. 2018 Dec;246(4):233-241. doi: 10.1620/tjem.246.233. Tohoku J Exp Med. 2018. PMID: 30541997
-
A novel mutation in the AGXT gene causing primary hyperoxaluria type I: genotype-phenotype correlation.J Genet. 2016 Sep;95(3):659-66. doi: 10.1007/s12041-016-0676-4. J Genet. 2016. PMID: 27659337
-
Primary hyperoxaluria type 1: update and additional mutation analysis of the AGXT gene.Hum Mutat. 2009 Jun;30(6):910-7. doi: 10.1002/humu.21021. Hum Mutat. 2009. PMID: 19479957 Review.
-
A vertical (pseudodominant) pattern of inheritance in the autosomal recessive disease primary hyperoxaluria type 1: lack of relationship between genotype, enzymic phenotype, and disease severity.Am J Kidney Dis. 1997 Jan;29(1):36-44. doi: 10.1016/s0272-6386(97)90006-8. Am J Kidney Dis. 1997. PMID: 9002528 Review.
Cited by
-
Clinical analysis of 13 children with primary hyperoxaluria type 1.Urolithiasis. 2021 Oct;49(5):425-431. doi: 10.1007/s00240-021-01249-3. Epub 2021 Mar 15. Urolithiasis. 2021. PMID: 33721035 Free PMC article.
-
Four novel variants identified in primary hyperoxaluria and genotypic and phenotypic analysis in 21 Chinese patients.Front Genet. 2023 Apr 17;14:1124745. doi: 10.3389/fgene.2023.1124745. eCollection 2023. Front Genet. 2023. PMID: 37139236 Free PMC article.
-
Mutation Characteristics of Primary Hyperoxaluria in the Chinese Population and Current International Diagnosis and Treatment Status.Kidney Dis (Basel). 2024 Jun 17;10(4):313-326. doi: 10.1159/000539516. eCollection 2024 Aug. Kidney Dis (Basel). 2024. PMID: 39131880 Free PMC article. Review.
-
Lumasiran for primary hyperoxaluria type 1: What we have learned?Front Pediatr. 2023 Jan 10;10:1052625. doi: 10.3389/fped.2022.1052625. eCollection 2022. Front Pediatr. 2023. PMID: 36704142 Free PMC article. Review.
-
Functional analysis of amino acid substitutions within human AGT1 in a cell-based platform to support the diagnosis of primary hyperoxaluria type 1.J Biol Chem. 2025 Jul 17;301(8):110494. doi: 10.1016/j.jbc.2025.110494. Online ahead of print. J Biol Chem. 2025. PMID: 40683450 Free PMC article.
References
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous